- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03706872
Efficacy of an App for Monitoring Physical Activity and Weight of Obese Pregnant Women (Pas&Pes) (Pas&Pes)
Efficacy of an App for Monitoring Physical Activity and Weight of Obese Pregnant Women
This study evaluate the efficacy of an App for monitoring the physical activity and weight with a smart watch and the provision of virtual advice through messages with a mobile phone in obese pregnant women in the second trimester.
Half of the women will be randomized at the intervention group (App + smart watch) and the other half, to the control group who will receive the usual prenatal care.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Randomized controlled trial among obese women. These women will be randomized in two groups in order to evaluate an improvement in several outcomes thanks to different strategies:
Intervention group (IG). An App for monitoring physical activity and weight with a smart watch and the administration of virtual advice through messages with mobile phone and the midwife's feedback, as well as the provision of usual prenatal care.
Control group. Pregnant women will receive the usual prenatal care. Main hypothesis: In the intervention group pregnant women will improve the weight gain adjusted to the preconception BMI, during pregnanacy, with respect to the pregnant women of the control group.
Secondary hypothesis. In the intervention group pregnant women will improve the physical activity.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08038
- Elena González-Plaza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women with BMI ≥ 30 Kg / m2 preconceptional
- Speak Spanish fluently
- Viable singleton non-malformed fetus
- 12-18 weeks of gestation
- Users of Android or Iphone smart mobile phone with internet connection
Exclusion Criteria:
- Pregnant women users of a physical activity and weight monitoring App
- Pregnant women with Type I or II Diabetes Mellitus
- Pregnant Women with psychiatric disorders
- Pregnant women with thyroid disorders
- Women with chronic hypertension
- Pregnant women who for some reason have contraindicated the performance of exercise or mobility problems that make it impossible to walk in a moderate way.
- Pregnant women who do not accept to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
The provision of an App for monitoring physical activity and weight with a smart watch and the administration of virtual advice through messages with mobile phone and the midwife's feedback, as well as the provision of usual prenatal care.
|
The provision of an App for monitoring physical activity and weight with a smart watch and the administration of virtual advice through messages with mobile phone and the midwife's feedback, as well as the provision of usual prenatal care
|
|
No Intervention: Control Group
Provision of usual prenatal care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gestational weight gain
Time Frame: 36 weeks
|
Compare gestational weight gain dring pregnancy in both groups.
|
36 weeks
|
|
Physical activity
Time Frame: 36 weeks
|
METS/minutes/week by the "IPAQ Scale" short version
|
36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gestational complications
Time Frame: 36 weeks
|
Prevalence of preeclampsia, gestational diabetes.
|
36 weeks
|
|
Intrapartum complications
Time Frame: Labor
|
Labor inductions and type of labor
|
Labor
|
|
perinatal complications
Time Frame: birth
|
Prevalence of prematurity, macrosomia
|
birth
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
App usability
Time Frame: 36 weeks
|
To describe the App usability using "System Usability Scale" in pregnant women of the experimental group
|
36 weeks
|
|
Eating habits
Time Frame: 36 weeks
|
Compare eating habits in both groups with "dietary habits questionaire for the overweight and obese"
|
36 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elena González-Plaza, Midwife, Clinic Hospital of Barcelona
- Study Director: Gloria Seguranyes, PhD, University of Barcelona
- Study Director: Jordi Bellart, PhD, Clinic Hospital of Barcelona
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HCB2017/0756
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obese Pregnant Women
-
Turku University HospitalUniversity of Turku; University of Helsinki; Hospital District of Helsinki and...RecruitingPregnancy | Weight Management | Postpartum | Usability | Obese Pregnant Women | Digital InterventionFinland
-
University Hospital, Clermont-FerrandCompleted
-
Assiut UniversityTerminatedMetformin for Obese Pregnant WomenEgypt
-
National Institute of Neurosciences and Hospital...Directorate General of Health Services, BangladeshActive, not recruitingPregnant Women | Pregnant Women and Their OffspringBangladesh
-
TC Erciyes UniversityNot yet recruitingHypotension in Pregnant Women | Headache in Pregnant Women
-
Mackay Medical CollegeCompletedOverweight and Obese Pregnant WomenTaiwan
-
Nantes University HospitalRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Tokat Gaziosmanpasa UniversityOndokuz Mayıs UniversityNot yet recruiting
-
Myant Medical Corp.McMaster UniversityNot yet recruiting
Clinical Trials on Intervention group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
Beijing HospitalThe First Hospital of Jilin University; Jilin University; Chinese Academy of...Not yet recruitingAsthma | Allergic Disease
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...Active, not recruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Suzhou) Pharmaceutical Co., Ltd.RecruitingPostmenopausal Women With OsteoporosisChina
-
TC Erciyes UniversityNot yet recruitingNeuropathic Pain | Type 2 Diabetes Mellitus (T2DM)Turkey (Türkiye)